Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by inventorson Dec 18, 2014 12:24pm
304 Views
Post# 23244817

RE:RE:RE:RE:RE:Major TSX index ---

RE:RE:RE:RE:RE:Major TSX index --- I'm in the francois camp..

Perhaps it is a strategy for acceptance in 100 index...worked for a fortune 50 years ago...too premature...lol.

There will be several indexes covering PLI, but they wont have the same noise and effect.

The deal is obviously tied to the same makeup as the FDA logistics on Phase testing, and once everything is cleared from all parties...

Push forward everything for 2015 balance sheets....
Bullboard Posts